Skip to main content

Envisioning is an emerging technology research institute and advisory.

LinkedInInstagramGitHub

2011 — 2026

research
  • Observatory
  • Newsletter
  • Methodology
  • Origins
  • Vocab
  • RSS Feeds
services
  • Signals Session
  • Bespoke Projects
  • Build Sessions
  • Pricing
  • Use Cases
  • Signals
  • Signal Scan↗free
impact
  • ANBIMAFuture of Brazilian Capital Markets
  • IEEECharting the Energy Transition
  • Horizon 2045Future of Human and Planetary Security
  • WKOTechnology Scanning for Austria
solutions
  • Innovation
  • Strategy
  • Consultants
  • Foresight
  • Associations
  • Governments
  • L&D
resources
  • Partners
  • Coding for Non-Coders
  • How We Work
  • Data Visualization
  • Multi-Model Method
  • FAQ
  • Security & Privacy
  • Public Sector
about
  • Manifesto
  • Community
  • Events
  • Support
  • Contact
ResearchServicesSignalsAbout
ResearchServicesSignalsAbout
  1. Home
  2. Research
  3. Helix
  4. Biology Foundation Models

Biology Foundation Models

Bioptimus (France, $35M seed) building a 'Universal Biology Model' — training AI on DNA, proteins, and cell images rather than text to accelerate drug discovery

Geography: Emea · Europe · Europe

Back to HelixBack to EuropeView interactive version

Bioptimus (Paris, spun off from Owkin) is creating foundation models trained not on internet text but on biological data: DNA sequences, protein structures, cell microscopy images, and clinical datasets. The goal is a general-purpose biological AI that can predict interactions across the entire molecular landscape of human disease.

The approach treats biology as a language problem: just as GPT learned language patterns from text, Bioptimus learns biological patterns from molecular and cellular data. Access to the Jean Zay supercomputer (France's national AI compute resource) enables training at the scale required for biological foundation models — a public-private partnership model distinctive to France.

Bioptimus sits in a Paris AI-for-biology cluster that includes Owkin (its parent company), Inria's computational biology teams, and Institut Pasteur. The combination of world-class biology research institutions and frontier AI talent makes France a natural home for the convergence of AI and life sciences. If successful, biological foundation models could compress drug discovery timelines from decades to years by predicting which molecules will work before synthesis.

TRL
5/9Validated
Impact
3/5
Investment
4/5
Category
Applications

Research this in Signals

Scan Biology Foundation Models for yourself.

Signals turns a topic into a sourced research record you can inspect and rerun. Your first scan is free, and this one starts with Biology Foundation Models already loaded, so edit it or scan as is.